Skip to main content
. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2

Fentiman 1986.

Methods Single centre RCT of intrapleural talc and tetracycline in MPE secondary to breast cancer (UK)
Participants Inclusion criteria: histologically confirmed breast cancer and a symptomatic pleural effusion on radiology
Exclusion criteria: previous treatment for effusion, other than simple needle aspiration; non‐malignant cause for effusion; unsuitable for general anaesthetic; history of sensitivity to tetracycline
41 participants randomised
Interventions Talc group: thoracoscopy, talc insufflated (dose not stated). Intercostal drain remained in situ for five days
Tetracycline group: thoracoscopy. Tetracycline 500 mg in 40 ml N saline inserted 16 ‐ 24 hours later via chest tube. Intercostal drain left in place for 3 ‐ 5 days
Outcomes Pleurodesis success (defined by lack of re‐accumulation on CXR); complications; mortality
Notes Pleurodesis success defined according to CXR only
Participants with trapped lung eligible for trial entry
Included in network meta‐analysis of pleurodesis efficacy and mortality.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomised with stratification for metastatic disease"
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not possible to blind patients or personnel due to the nature of the procedures
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not stated whether radiographic interpretation of CXRs were performed by a blinded person. Reporting of complications could be biased by lack of participant and personnel blinding
Incomplete outcome data (attrition bias) 
 All outcomes High risk Participants were excluded from the primary analysis if they died within the first month. Higher proportion of deaths in the talc group (6/18 = 33%) compared to the tetracycline group (2/23 = 9%)
Selective reporting (reporting bias) Low risk All stated outcomes reported
Other bias Low risk No other biases identified